Gå direkt till huvudinnehållet

Vaginal flytning

Senast uppdaterad: Senast reviderad:
Sakkunnig:

  1. Mitchell H. Vaginal discharge - causes, diagnosis, and treatment. BMJ 2004; 328: 1306-8. PubMed  
  2. Eckert LO. Acute vulvovaginitis. N Engl J Med 2006; 355: 1244-52. PubMed  
  3. Spence D, Melville C. Vaginal discharge. BMJ 2007; 335: 1147-51. PubMed  
  4. Owen MK, Clenney TL. Management of vaginitis. Am Fam Physician 2004; 70: 2125-32. PubMed  
  5. Hainer BL, Gibson MV. Vaginitis: Diagnosis and treatment. Am Fam Physician 2011; 83: 807-15. American Family Physician  
  6. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 1991; 174: 289-92. PubMed  
  7. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 1998; 92: 757-65. PubMed  
  8. Sobel JD. Vaginitis. N Engl J Med 1997; 337: 1896-903. New England Journal of Medicine  
  9. Ison CA, Taylor-Robinson D. Bacterial vaginosis. Int J STD AIDS 1997; 8: 1-42. PubMed  
  10. Hay PE, Taylor-Robinson D. Defining bacterial vaginosis: to BV or not to BV, that is the question. Int J STD AIDS 1996; 7: 233-5. PubMed  
  11. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22. PubMed  
  12. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect 2004; 80: 8-11. PubMed  
  13. Irving G, Miller D, Robinson A, Reynolds S, Copas AJ. Psychological factors associated with recurrent vaginal candidiasis: a preliminary study. Sex Transm Inf 1998; 74: 334-8. PubMed  
  14. Rodgers CA, Beardall AJ. Recurrent vulvo-vaginal candidiasis: why does it occur? Continuing medical education. Int J STD AIDS 1999; 10: 435-41. PubMed  
  15. Soper D. Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 2004; 190: 281-90. PubMed  
  16. Low N, Egger M, Sterne JA, Harbord R, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala women's cohort study. Sex Transm Infect 2006; 82: 212-8. PubMed  
  17. Morré SA, van den Brule AJC, Rozendaal L, Boeke AJ, Voorhorst FJ, de Blok S, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow up. Int J STD AIDS 2002; 13(suppl 2): 12-8.
  18. Fischer G, Bradford J. Persistent vaginitis. Practice pointer. BMJ 2011; 343: d7314. BMJ (DOI)  
  19. Bornstein J, Lakovsky Y, Lavi I, Bar-Am A, Abramovici H. The classic approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol 2001; 9: 105-11. PubMed  
  20. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291: 1368-79. Journal of the American Medical Association  
  21. Van Bergen JE, Spaargaren J, Gotz HM, Veldhuijzen IK, Bindels PJ, Coenen TJ, et al. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found? BMC Infect Dis 2006; 6: 42. PubMed  
  22. Kalwij S, Macintosh M, Baraitser P. Screening and treatment of Chlamydia trachomatis infections. Clinical review. BMJ 2010; 340: c1915. BMJ (DOI)  
  23. Urinprov vid diagnostik av klamydia hos kvinnor. SBU Alert-rapport nr. 2010 - 05
  24. Sexuellt överförbara bakteriella infektioner-behandlingsrekommendation www.lakemedelsverket.se  
  • Barbro Larson, docent och specialist i gynekologi och obstetrik, Stockholm
  • Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet